Prelude Therapeutics Announces Pricing of Initial Public Offering
September 24, 2020 20:50 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the pricing of its initial public...